FDA approves R2 CAD

Article

R2 Technology's proprietary mammography CAD has been approved by the FDA for sale with Fischer Imaging's SenoScan TrueView digital mammography system. Fischer plans to integrate R2's ImageChecker technology with SenoScan to support CAD analysis of

R2 Technology's proprietary mammography CAD has been approved by the FDA for sale with Fischer Imaging's SenoScan TrueView digital mammography system. Fischer plans to integrate R2's ImageChecker technology with SenoScan to support CAD analysis of digital mammograms.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Current and Emerging Legislative Priorities for Radiology in 2025
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
Nina Kottler, MD, MS
Radiology Challenges with Breast Cancer Screening in Women with Breast Implants
Related Content
© 2025 MJH Life Sciences

All rights reserved.